Form Type: 4

SEC EDGAR Link
Accession Number:0001171843-20-006337
Date:2020-09-03
Issuer: ANIKA THERAPEUTICS, INC. (ANIK)
Original Submission Date:

Reporting Person:

RICHARD STEPHEN
32 WIGGINS AVENUE
BEDFORD, MA 01730

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-09-03 A 9,310 a $0.00 9,310 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 these shares represent restricted stock units. each restricted stock unit represents the contingent right to receive one share of anika therapeutics, inc. common stock. the restricted stock units vest in three equal annual installments immediately prior to the anika therapeutics, inc., annual meetings of stockholders in 2021, 2022, and 2023.
WhaleWisdom Logo

Elevate your investments